Richard Law
Stock Analyst at Goldman Sachs
(0)
# 4623
Out of 5,297 analysts
59
Total ratings
23.08%
Success rate
-18.95%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RCKT Rocket Pharmaceutica... | Maintains: Neutral | 29 15 | 6.28 | 138.85% | 2 | Mar 3, 2025 | |
CLDX Celldex Therapeutics | Maintains: Neutral | 42 36 | 17.45 | 106.3% | 2 | Mar 3, 2025 | |
MLTX MoonLake | Maintains: Buy | 82 73 | 38.06 | 91.8% | 3 | Feb 27, 2025 | |
MLYS Mineralys Therapeuti... | Maintains: Buy | 28 24 | 13.95 | 72.04% | 6 | Feb 13, 2025 | |
VRDN Viridian Therapeutic... | Maintains: Strong Buy | 25 31 | 13.1 | 136.64% | 2 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 3.42 | 601.75% | 4 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 11 | 4.42 | 148.87% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 31 | 3.85 | 705.19% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 47 | 18.48 | 154.33% | 3 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 62 63 | 34.2 | 84.21% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 36 37 | 26.38 | 40.26% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 76 | 7.32 | 938.25% | 6 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 36 | n/a | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 14 | 1.19 | 1076.47% | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 61 | 7.15 | 753.15% | 4 | May 8, 2023 |